Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items (2020 - 2023)

Historic Non-cash Items for Relay Therapeutics (RLAY) over the last 4 years, with Q4 2023 value amounting to $18.9 million.

  • Relay Therapeutics' Non-cash Items fell 4542.96% to $18.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $18.9 million, marking a year-over-year decrease of 4542.96%. This contributed to the annual value of $18.9 million for FY2023, which is 4542.96% down from last year.
  • As of Q4 2023, Relay Therapeutics' Non-cash Items stood at $18.9 million, which was down 4542.96% from $34.6 million recorded in Q4 2022.
  • Relay Therapeutics' Non-cash Items' 5-year high stood at $196.6 million during Q4 2020, with a 5-year trough of $18.9 million in Q4 2023.
  • In the last 4 years, Relay Therapeutics' Non-cash Items had a median value of $72.8 million in 2021 and averaged $90.3 million.
  • As far as peak fluctuations go, Relay Therapeutics' Non-cash Items crashed by 4353.93% in 2021, and later tumbled by 6879.24% in 2022.
  • Over the past 4 years, Relay Therapeutics' Non-cash Items (Quarter) stood at $196.6 million in 2020, then plummeted by 43.54% to $111.0 million in 2021, then crashed by 68.79% to $34.6 million in 2022, then plummeted by 45.43% to $18.9 million in 2023.
  • Its last three reported values are $18.9 million in Q4 2023, $34.6 million for Q4 2022, and $111.0 million during Q4 2021.